Use and Abuse of Benzodiazepines in Hong Kong 1990-1993 - The Impact of Regulatory Changes

Abstract To control benzodiazepine abuse in Hong Kong, the Government's Pharmacy and Poisons Board reclassified benzodiazepines as Dangerous Drugs in October 1990. Apart from formal prescriptions, detailed records were then required for the supply and dispensing of these drugs. These regulation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical toxicology (Philadelphia, Pa.) Pa.), 1995, Vol.33 (6), p.597-602
Hauptverfasser: Lee, Kenneth K.C., Chan, Thomas Y.K., Chan, Anthony W.K., Lau, Grace S.N., Critchley, Julian A.J.H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 602
container_issue 6
container_start_page 597
container_title Clinical toxicology (Philadelphia, Pa.)
container_volume 33
creator Lee, Kenneth K.C.
Chan, Thomas Y.K.
Chan, Anthony W.K.
Lau, Grace S.N.
Critchley, Julian A.J.H.
description Abstract To control benzodiazepine abuse in Hong Kong, the Government's Pharmacy and Poisons Board reclassified benzodiazepines as Dangerous Drugs in October 1990. Apart from formal prescriptions, detailed records were then required for the supply and dispensing of these drugs. These regulations were applied initially only to brotizolam, triazolam and flunitrazepam, and were extended in January 1992 to include all benzodiazepines. The impact of these regulatory changes on benzodiazepine use has been studied by analyzing the sales patterns of seven benzodiazepines between 1990-1993. In 1991, the sales of flunitrazepam and triazolam fell, but the sales of five unrestricted benzodiazepines increased. In 1992-1993, the sales of all but one of the benzodiazepines fell. Comparing 1993 to 1990, the fall in sales was particularly marked for triazolam, chlordiazepoxide and flunitrazepam. A regulation requiring the use of proper prescriptions and detailed records for the supply and dispensing of benzodiazepines, appears to have curbed, at least partially, their abuse in Hong Kong.
doi_str_mv 10.3109/15563659509010615
format Article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_2937149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>8523479</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-8eabe8333d8ebdb8fb46d90fcc6ba2dfd6c6232f42ab85b2cefd52dfacb509f3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMoun78AA9CDl6rSdPUBr2si18oCLJevJTJ17bSJkvSRXZ_vS27CiLsZWaYeZ9h5kXolJILRom4pJznLOeCE0EoySnfQaOhlwhOxe6m7gXkAB3G-EkIKzJB99F-wVOWXYkR-niPBoPTeCwXfeUtvjVu5XUNKzOvnYm4dvjRuxl-HgIVgiR9YDjB08rgp3YOqhuwNzNbNND5sMSTCtzMxGO0Z6GJ5mSTj9D0_m46eUxeXh-eJuOXRGWMdElhQJqCMaYLI7UsrMxyLYhVKpeQaqtzlacstVkKsuAyVcZq3vdByf5ty44QXa9VwccYjC3noW4hLEtKysGl8p9LPXO2ZuYL2Rr9S2xs6efnmzlEBY0N4FQdf2WpYFc0G2Q3a1ntrA8tfPnQ6LKDZePDD8O2XXH9B68MNF2lIJjy0y-C603b8sM3x3qTkQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Use and Abuse of Benzodiazepines in Hong Kong 1990-1993 - The Impact of Regulatory Changes</title><source>MEDLINE</source><source>Taylor &amp; Francis:Master (3349 titles)</source><source>Taylor &amp; Francis Medical Library - CRKN</source><creator>Lee, Kenneth K.C. ; Chan, Thomas Y.K. ; Chan, Anthony W.K. ; Lau, Grace S.N. ; Critchley, Julian A.J.H.</creator><creatorcontrib>Lee, Kenneth K.C. ; Chan, Thomas Y.K. ; Chan, Anthony W.K. ; Lau, Grace S.N. ; Critchley, Julian A.J.H.</creatorcontrib><description>Abstract To control benzodiazepine abuse in Hong Kong, the Government's Pharmacy and Poisons Board reclassified benzodiazepines as Dangerous Drugs in October 1990. Apart from formal prescriptions, detailed records were then required for the supply and dispensing of these drugs. These regulations were applied initially only to brotizolam, triazolam and flunitrazepam, and were extended in January 1992 to include all benzodiazepines. The impact of these regulatory changes on benzodiazepine use has been studied by analyzing the sales patterns of seven benzodiazepines between 1990-1993. In 1991, the sales of flunitrazepam and triazolam fell, but the sales of five unrestricted benzodiazepines increased. In 1992-1993, the sales of all but one of the benzodiazepines fell. Comparing 1993 to 1990, the fall in sales was particularly marked for triazolam, chlordiazepoxide and flunitrazepam. A regulation requiring the use of proper prescriptions and detailed records for the supply and dispensing of benzodiazepines, appears to have curbed, at least partially, their abuse in Hong Kong.</description><identifier>ISSN: 1556-3650</identifier><identifier>ISSN: 0731-3810</identifier><identifier>EISSN: 1556-9519</identifier><identifier>EISSN: 1097-9875</identifier><identifier>DOI: 10.3109/15563659509010615</identifier><identifier>PMID: 8523479</identifier><language>eng</language><publisher>Monticello, NY: Informa UK Ltd</publisher><subject>benzodiazepines ; Benzodiazepines - economics ; Benzodiazepines - pharmacology ; Benzodiazepines - poisoning ; Biological and medical sciences ; drue abuse ; Drug and Narcotic Control - statistics &amp; numerical data ; Drug intoxications. Doping ; Drug Prescriptions - economics ; Drug Prescriptions - statistics &amp; numerical data ; Drug Utilization Review - statistics &amp; numerical data ; Hong Kong ; Horn Kong ; Humans ; Medical sciences ; Pharmacology. Drug treatments ; reeulation ; Substance-Related Disorders - epidemiology ; Substance-Related Disorders - prevention &amp; control</subject><ispartof>Clinical toxicology (Philadelphia, Pa.), 1995, Vol.33 (6), p.597-602</ispartof><rights>1995 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1995</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-8eabe8333d8ebdb8fb46d90fcc6ba2dfd6c6232f42ab85b2cefd52dfacb509f3</citedby><cites>FETCH-LOGICAL-c430t-8eabe8333d8ebdb8fb46d90fcc6ba2dfd6c6232f42ab85b2cefd52dfacb509f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/15563659509010615$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/15563659509010615$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,4023,4049,4050,23929,23930,25139,27922,27923,27924,59646,59752,60435,60541,61220,61255,61401,61436</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2937149$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8523479$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Kenneth K.C.</creatorcontrib><creatorcontrib>Chan, Thomas Y.K.</creatorcontrib><creatorcontrib>Chan, Anthony W.K.</creatorcontrib><creatorcontrib>Lau, Grace S.N.</creatorcontrib><creatorcontrib>Critchley, Julian A.J.H.</creatorcontrib><title>Use and Abuse of Benzodiazepines in Hong Kong 1990-1993 - The Impact of Regulatory Changes</title><title>Clinical toxicology (Philadelphia, Pa.)</title><addtitle>J Toxicol Clin Toxicol</addtitle><description>Abstract To control benzodiazepine abuse in Hong Kong, the Government's Pharmacy and Poisons Board reclassified benzodiazepines as Dangerous Drugs in October 1990. Apart from formal prescriptions, detailed records were then required for the supply and dispensing of these drugs. These regulations were applied initially only to brotizolam, triazolam and flunitrazepam, and were extended in January 1992 to include all benzodiazepines. The impact of these regulatory changes on benzodiazepine use has been studied by analyzing the sales patterns of seven benzodiazepines between 1990-1993. In 1991, the sales of flunitrazepam and triazolam fell, but the sales of five unrestricted benzodiazepines increased. In 1992-1993, the sales of all but one of the benzodiazepines fell. Comparing 1993 to 1990, the fall in sales was particularly marked for triazolam, chlordiazepoxide and flunitrazepam. A regulation requiring the use of proper prescriptions and detailed records for the supply and dispensing of benzodiazepines, appears to have curbed, at least partially, their abuse in Hong Kong.</description><subject>benzodiazepines</subject><subject>Benzodiazepines - economics</subject><subject>Benzodiazepines - pharmacology</subject><subject>Benzodiazepines - poisoning</subject><subject>Biological and medical sciences</subject><subject>drue abuse</subject><subject>Drug and Narcotic Control - statistics &amp; numerical data</subject><subject>Drug intoxications. Doping</subject><subject>Drug Prescriptions - economics</subject><subject>Drug Prescriptions - statistics &amp; numerical data</subject><subject>Drug Utilization Review - statistics &amp; numerical data</subject><subject>Hong Kong</subject><subject>Horn Kong</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>reeulation</subject><subject>Substance-Related Disorders - epidemiology</subject><subject>Substance-Related Disorders - prevention &amp; control</subject><issn>1556-3650</issn><issn>0731-3810</issn><issn>1556-9519</issn><issn>1097-9875</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMoun78AA9CDl6rSdPUBr2si18oCLJevJTJ17bSJkvSRXZ_vS27CiLsZWaYeZ9h5kXolJILRom4pJznLOeCE0EoySnfQaOhlwhOxe6m7gXkAB3G-EkIKzJB99F-wVOWXYkR-niPBoPTeCwXfeUtvjVu5XUNKzOvnYm4dvjRuxl-HgIVgiR9YDjB08rgp3YOqhuwNzNbNND5sMSTCtzMxGO0Z6GJ5mSTj9D0_m46eUxeXh-eJuOXRGWMdElhQJqCMaYLI7UsrMxyLYhVKpeQaqtzlacstVkKsuAyVcZq3vdByf5ty44QXa9VwccYjC3noW4hLEtKysGl8p9LPXO2ZuYL2Rr9S2xs6efnmzlEBY0N4FQdf2WpYFc0G2Q3a1ntrA8tfPnQ6LKDZePDD8O2XXH9B68MNF2lIJjy0y-C603b8sM3x3qTkQ</recordid><startdate>1995</startdate><enddate>1995</enddate><creator>Lee, Kenneth K.C.</creator><creator>Chan, Thomas Y.K.</creator><creator>Chan, Anthony W.K.</creator><creator>Lau, Grace S.N.</creator><creator>Critchley, Julian A.J.H.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Dekker</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1995</creationdate><title>Use and Abuse of Benzodiazepines in Hong Kong 1990-1993 - The Impact of Regulatory Changes</title><author>Lee, Kenneth K.C. ; Chan, Thomas Y.K. ; Chan, Anthony W.K. ; Lau, Grace S.N. ; Critchley, Julian A.J.H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-8eabe8333d8ebdb8fb46d90fcc6ba2dfd6c6232f42ab85b2cefd52dfacb509f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>benzodiazepines</topic><topic>Benzodiazepines - economics</topic><topic>Benzodiazepines - pharmacology</topic><topic>Benzodiazepines - poisoning</topic><topic>Biological and medical sciences</topic><topic>drue abuse</topic><topic>Drug and Narcotic Control - statistics &amp; numerical data</topic><topic>Drug intoxications. Doping</topic><topic>Drug Prescriptions - economics</topic><topic>Drug Prescriptions - statistics &amp; numerical data</topic><topic>Drug Utilization Review - statistics &amp; numerical data</topic><topic>Hong Kong</topic><topic>Horn Kong</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>reeulation</topic><topic>Substance-Related Disorders - epidemiology</topic><topic>Substance-Related Disorders - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Kenneth K.C.</creatorcontrib><creatorcontrib>Chan, Thomas Y.K.</creatorcontrib><creatorcontrib>Chan, Anthony W.K.</creatorcontrib><creatorcontrib>Lau, Grace S.N.</creatorcontrib><creatorcontrib>Critchley, Julian A.J.H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Clinical toxicology (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Kenneth K.C.</au><au>Chan, Thomas Y.K.</au><au>Chan, Anthony W.K.</au><au>Lau, Grace S.N.</au><au>Critchley, Julian A.J.H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use and Abuse of Benzodiazepines in Hong Kong 1990-1993 - The Impact of Regulatory Changes</atitle><jtitle>Clinical toxicology (Philadelphia, Pa.)</jtitle><addtitle>J Toxicol Clin Toxicol</addtitle><date>1995</date><risdate>1995</risdate><volume>33</volume><issue>6</issue><spage>597</spage><epage>602</epage><pages>597-602</pages><issn>1556-3650</issn><issn>0731-3810</issn><eissn>1556-9519</eissn><eissn>1097-9875</eissn><abstract>Abstract To control benzodiazepine abuse in Hong Kong, the Government's Pharmacy and Poisons Board reclassified benzodiazepines as Dangerous Drugs in October 1990. Apart from formal prescriptions, detailed records were then required for the supply and dispensing of these drugs. These regulations were applied initially only to brotizolam, triazolam and flunitrazepam, and were extended in January 1992 to include all benzodiazepines. The impact of these regulatory changes on benzodiazepine use has been studied by analyzing the sales patterns of seven benzodiazepines between 1990-1993. In 1991, the sales of flunitrazepam and triazolam fell, but the sales of five unrestricted benzodiazepines increased. In 1992-1993, the sales of all but one of the benzodiazepines fell. Comparing 1993 to 1990, the fall in sales was particularly marked for triazolam, chlordiazepoxide and flunitrazepam. A regulation requiring the use of proper prescriptions and detailed records for the supply and dispensing of benzodiazepines, appears to have curbed, at least partially, their abuse in Hong Kong.</abstract><cop>Monticello, NY</cop><pub>Informa UK Ltd</pub><pmid>8523479</pmid><doi>10.3109/15563659509010615</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1556-3650
ispartof Clinical toxicology (Philadelphia, Pa.), 1995, Vol.33 (6), p.597-602
issn 1556-3650
0731-3810
1556-9519
1097-9875
language eng
recordid cdi_pascalfrancis_primary_2937149
source MEDLINE; Taylor & Francis:Master (3349 titles); Taylor & Francis Medical Library - CRKN
subjects benzodiazepines
Benzodiazepines - economics
Benzodiazepines - pharmacology
Benzodiazepines - poisoning
Biological and medical sciences
drue abuse
Drug and Narcotic Control - statistics & numerical data
Drug intoxications. Doping
Drug Prescriptions - economics
Drug Prescriptions - statistics & numerical data
Drug Utilization Review - statistics & numerical data
Hong Kong
Horn Kong
Humans
Medical sciences
Pharmacology. Drug treatments
reeulation
Substance-Related Disorders - epidemiology
Substance-Related Disorders - prevention & control
title Use and Abuse of Benzodiazepines in Hong Kong 1990-1993 - The Impact of Regulatory Changes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T18%3A07%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20and%20Abuse%20of%20Benzodiazepines%20in%20Hong%20Kong%201990-1993%20-%20The%20Impact%20of%20Regulatory%20Changes&rft.jtitle=Clinical%20toxicology%20(Philadelphia,%20Pa.)&rft.au=Lee,%20Kenneth%20K.C.&rft.date=1995&rft.volume=33&rft.issue=6&rft.spage=597&rft.epage=602&rft.pages=597-602&rft.issn=1556-3650&rft.eissn=1556-9519&rft_id=info:doi/10.3109/15563659509010615&rft_dat=%3Cpubmed_pasca%3E8523479%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/8523479&rfr_iscdi=true